Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Oil Prices Rise as Dollar Gains Ahead of Key U.S. Inflation Data 
Gold Prices Slip as Strong Dollar and Rising Oil Weigh on Market Sentiment 
Trump Says Iran Ceasefire Near Collapse as Oil Prices Surge 
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
